ArticleJournal of medical economicsPublished
Cost per responder for teclistamab and elranatamab in relapsed or refractory multiple myeloma in the United States
Regional connection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
- Institution
- Johnson & Johnson
- County
- Montgomery County
Publication record
- Type
- Article
- Venue
- Journal of medical economics
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Multiple Myeloma; Antineoplastic Agents; Models, Econometric; Aged; Middle Aged; Cost-Benefit Analysis; United States; Female; Male; Multicenter Studies as Topic; Clinical Trials, Phase I as Topic
- PubMed ID
- 40495704
- Added to directory
- Source checked